About this Research Topic
However, preventive chemotherapy is not efficient against three NTDs with the highest rates of death, namely Leishmaniasis, American Trypanosomiasis and African Trypanosomiasis. Furthermore, the use of current available treatments is limited because of their toxicity and the emergence of resistant forms of the causative parasite. In addition to this, current chemotherapeutic interventions have seen variable efficacy between strains or species, toxicity, parenteral administration, requirement for long courses of administration, adverse effects and high costs. As a result, there is now an urgent need to search for new alternative treatments including bioactive based nanocarriers.
The long-term goal of this Research Topic is to identify new nanoparticles and nanomaterials as drugs or carriers of antiprotozoals molecules to treat NTDs.
The collection will report research about the production of bioactive-based nanomaterials against protozoa, some examples including Leishmania, Trypanosoma, Free Living Amoeba and Plasmodium. All research papers within this scope are welcome as original research, reviews and clinical trials.
Keywords: Biomolecules, Nanoparticles, Nanocarriers, Antiprotozoal Chemotherapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.